Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:
Cha HM; Kim UI; Ahn SB; Lee MK; Lee H and 6 more

Journal:
ACS Infect Dis

Publication Year: 2023

DOI:
10.1021/acsinfecdis.3c00034

PMCID:
PMC10081574

PMID:
36912867

Journal Information

Full Title: ACS Infect Dis

Abbreviation: ACS Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare no competing financial interest."

Evidence found in paper:

"This work was supported by the National Research Foundation of Korea (NRF) grant (NRF-2018M3A9H4089601) from the Korea Government (MSIT) and funded by the Ministry of Health and Welfare, Republic of Korea (HI22C2067). It was also supported by an intramural grant (KK1806-G06) from KRICT and an industrial research grant (IKT1806G06) from ST Pharm. The SARS-CoV-2 resource (NCCP no., 43328) was provided by the National Culture Collection for Pathogens, Republic of Korea."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025